What is Minerva Neurosciences Inc?
, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 114.62M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.